Discomfort, pain, bruising, inflammation, injury, and numbness at the site of injection
If needed, GLP-1 medicationonly as a tool, not a substitute for movement
daily energy restriction on weight loss and metabolic disease risk markers in overweight women.Harvie M1, Wright C, Pegington M, McMullan D, Mitchell E, Martin B, Cutler RG, Evans G, Whiteside S, Maudsley S, Camandola S, Wang R, Carlson OD, Egan JM, Mattson MP, Howell A Short- and long-term effects of continuous versus intermittent restrictive diet approaches on body composition and the metabolic profile in overweight and obese postmenopausal women: a pilot study.Arguin H1, Dionne IJ, Snchal M, Bouchard DR, Carpentier AC, Ardilouze JL, Tremblay A, Leblanc C, Brochu M
Peptides with a long half-life (like Semaglutide or CJC-1295 w/ DAC) are administered weekly
Please note that availability may not be accurate due to inventory fluctuations